Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 4.32%-61.49M | ---- | -4,590.44%-64.26M | ---- | 70.94%-1.37M | ---- | -114.12%-4.72M | ---- | 262.61%33.4M |
| Profit adjustment | ||||||||||
| Attributable subsidiary (profit) loss | ---- | 35.12%17.81M | ---- | 206.00%13.18M | ---- | -39.12%-12.44M | ---- | 48.84%-8.94M | ---- | -399.60%-17.48M |
| Impairment and provisions: | ---- | -47.46%19.6M | ---- | 676.16%37.31M | ---- | 372.66%4.81M | ---- | -75.10%1.02M | ---- | -70.35%4.08M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -94.96%36K | ---- | -39.59%714K |
| -Impairmen of inventory (reversal) | ---- | --2.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -97.47%596K | ---- | --23.55M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | --8.81M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 232.53%16.48M | ---- | 3.08%4.96M | ---- | 390.01%4.81M | ---- | -70.89%981K | ---- | -73.23%3.37M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.44M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.44M | ---- | ---- |
| Depreciation and amortization: | ---- | -70.58%681K | ---- | -78.19%2.32M | ---- | -19.76%10.61M | ---- | -37.58%13.23M | ---- | -45.99%21.19M |
| -Amortization of intangible assets | ---- | ---- | ---- | 29.28%1.36M | ---- | 52,500.00%1.05M | ---- | -33.33%2K | ---- | 0.00%3K |
| Financial expense | ---- | -40.00%18K | ---- | -89.05%30K | ---- | -69.92%274K | ---- | -51.39%911K | ---- | -33.92%1.87M |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | --360K | ---- | ---- | ---- | ---- |
| Special items | ---- | 17.91%-3.08M | ---- | -100.75%-3.75M | ---- | 23.99%-1.87M | ---- | 23.81%-2.46M | ---- | 35.38%-3.22M |
| Operating profit before the change of operating capital | ---- | -74.37%-26.45M | ---- | -4,080.84%-15.17M | ---- | 115.89%381K | ---- | -106.01%-2.4M | ---- | 48.60%39.85M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | 111.66%311K | ---- | -38,214.29%-2.67M | ---- | -97.92%7K | ---- | 157.25%337K |
| Accounts receivable (increase)decrease | ---- | -52.72%1.12M | ---- | 109.24%2.37M | ---- | -107.68%-25.63M | ---- | 225.22%333.89M | ---- | -462.92%-266.65M |
| Accounts payable increase (decrease) | ---- | 167.47%2.72M | ---- | -143.40%-4.03M | ---- | 102.76%9.29M | ---- | -209.00%-336.94M | ---- | 1,942.29%309.12M |
| prepayments (increase)decrease | ---- | 260.94%4.31M | ---- | -95.35%1.19M | ---- | 40.29%25.66M | ---- | 156.54%18.29M | ---- | -2,917.44%-32.35M |
| Special items for working capital changes | ---- | 1,043.42%10.39M | ---- | 77.23%-1.1M | ---- | 16.07%-4.84M | ---- | ---5.76M | ---- | ---- |
| Cash from business operations | -1,287.52%-18.83M | 51.83%-7.91M | 112.68%1.59M | -847.50%-16.43M | -186.52%-12.51M | -68.99%2.2M | 388.77%14.45M | -85.91%7.09M | -86.70%2.96M | 891.74%50.32M |
| Hong Kong profits tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -86.21%16K | ---- | 782.35%116K |
| China income tax paid | ---- | ---- | ---- | -124.33%-247K | ---- | 137.26%1.02M | ---- | -194.49%-2.72M | ---- | ---925K |
| Other taxs | ---- | ---- | ---- | ---- | -69.85%344K | ---- | 147.48%1.14M | ---- | ---2.4M | ---- |
| Interest received - operating | -30.26%1.39M | 462.15%2.82M | 49.74%1.99M | -75.97%502K | 86.68%1.33M | -8.10%2.09M | -44.86%713K | -24.03%2.27M | -42.53%1.29M | 135.22%2.99M |
| Interest paid - operating | ---1.35M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | -625.06%-18.79M | 68.52%-5.09M | 133.05%3.58M | -405.07%-16.18M | -166.41%-10.83M | -20.29%5.3M | 782.89%16.31M | -87.33%6.65M | -92.45%1.85M | 1,129.37%52.5M |
| Cash flow from investment activities | ||||||||||
| Loan receivable (increase) decrease | --2.76M | 184.10%6.84M | ---- | -9.70%-8.13M | -31.13%-11.9M | 25.85%-7.42M | ---9.08M | ---10M | ---- | ---- |
| Purchase of fixed assets | -12,772.22%-11.59M | -13,616.67%-823K | ---90K | 99.30%-6K | ---- | ---856K | ---11K | ---- | ---- | 98.79%-27K |
| Purchase of intangible assets | ---- | ---5.02M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | --27.87M | --27.87M | ---- | ---- | ---- | ---- | --4M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | --2.39M | --2.39M | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | --10.21M | ---- | ---- | 66.67%25M | 66.67%25M | -76.92%15M |
| Cash on investment | ---- | ---12.61M | ---- | ---- | ---10M | ---- | ---- | ---- | ---- | 44.23%-25M |
| Other items in the investment business | 125.74%763K | ---- | --338K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -3,350.81%-8.06M | -158.87%-11.61M | -98.47%248K | 435.42%19.73M | 341.61%16.18M | -139.21%-5.88M | -126.78%-6.7M | 348.76%15M | 1,167.11%25M | -300.07%-6.03M |
| Net cash before financing | -801.70%-26.85M | -570.40%-16.7M | -28.44%3.83M | 713.30%3.55M | -44.36%5.35M | -102.67%-579K | -64.20%9.61M | -53.40%21.65M | 1.49%26.85M | 2,327.61%46.47M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --17.35M | ---- | ---- | ---- | ---- | ---- | ---- | ---11.82M | -2.51%11.06M | ---- |
| Refund | ---5.46M | ---- | ---- | ---- | ---- | -201.83%-111K | 99.31%-100K | 100.89%109K | 37.69%-14.41M | 77.00%-12.23M |
| Issuing shares | ---- | --29M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 72.73%-3K | 40.00%-18K | 63.33%-11K | 89.05%-30K | 80.13%-30K | 69.45%-274K | 88.07%-151K | 61.75%-897K | 37.70%-1.27M | -42.04%-2.35M |
| Net cash from financing operations | 4,248.21%11.62M | 2,642.03%28.37M | 74.31%-280K | 91.71%-1.12M | 85.68%-1.09M | 55.87%-13.46M | 45.89%-7.61M | 27.16%-30.51M | 49.78%-14.07M | -138.61%-41.89M |
| Effect of rate | 697.62%251K | 114.30%202K | -102.52%-42K | -11,675.00%-1.41M | 215.56%1.66M | -103.32%-12K | -230.43%-1.44M | 146.64%361K | 503.28%1.1M | -1,884.62%-774K |
| Other items affecting net cash | ---- | ---- | ---- | ---268K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net Cash | -529.63%-15.24M | 438.30%11.67M | -16.70%3.55M | 115.43%2.17M | 112.79%4.26M | -58.52%-14.04M | -84.35%2M | -293.41%-8.86M | 920.94%12.78M | 123.32%4.58M |
| Begining period cash | 113.13%22.36M | 7.74%10.49M | 7.74%10.49M | -59.08%9.74M | -59.08%9.74M | -26.32%23.79M | -26.32%23.79M | 13.36%32.29M | 13.36%32.29M | -40.86%28.48M |
| Cash at the end | -47.35%7.37M | 113.13%22.36M | -10.62%14M | 7.74%10.49M | -35.70%15.66M | -59.08%9.74M | -47.26%24.35M | -26.32%23.79M | 70.34%46.17M | 13.36%32.29M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | ZTE Zheng Zheng Certified Public Accountants Co., Ltd. | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Rosenmei Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.